AVITA Medical (RCEL) Interest Expenses (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Interest Expenses data on file, last reported at $1.2 million in Q4 2025.

• For the quarter ending Q4 2025, Interest Expenses fell 3.7% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $5.0 million (down 6.66% YoY), and the FY2025 full-year result was $5.0 million, down 6.66% from the prior year.
• Interest Expenses for Q4 2025 stood at $1.2 million, down from $1.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $1.4 million in Q3 2024 and bottomed at $3000.0 in Q1 2021.
• The 5-year median for Interest Expenses is $1.1 million (2023), against an average of $678764.7.
• The widest annual swing landed in 2021, when Interest Expenses slumped 40.0%; it then surged 33800.0% in 2024.
• A 5-year view of Interest Expenses shows it stood at $9000.0 in 2021, then tumbled by 33.33% to $6000.0 in 2022, then surged by 18600.0% to $1.1 million in 2023, then grew by 15.69% to $1.3 million in 2024, then slipped by 3.7% to $1.2 million in 2025.
• The last three Interest Expenses figures came in at $1.2 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.

Peer Comparison